Clinical Trial Update: Edoxaban Treatment in Routine Clinical Practice in Patients With Venous Thromboembolism in Europe

View source ↗

Summary

This is a real-world clinical trial update on edoxaban use for venous thromboembolism in Europe. The results were posted in May 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venous Thromboembolism

Drugs mentioned

• Edoxaban (edoxaban)
• Lixiana (edoxaban)

Snippet

Sponsor: Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company | Conditions: Venous Thromboembolism | Status: COMPLETED | Results posted: 2022-05-02